These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32490170)

  • 1. The m
    Meng Z; Yuan Q; Zhao J; Wang B; Li S; Offringa R; Jin X; Wu H
    Mol Ther Oncolytics; 2020 Jun; 17():460-470. PubMed ID: 32490170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
    Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
    Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
    Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
    Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
    Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
    Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
    Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
    Front Genet; 2021; 12():692953. PubMed ID: 34490033
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma.
    Li J; Li W; Wang H; Ni B; Liu Y
    Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36660936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
    Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
    J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
    Mao M; Ling H; Lin Y; Chen Y; Xu B; Zheng R
    Front Genet; 2021; 12():702102. PubMed ID: 34335699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma.
    Zhao Q; Ye Y; Zhang Q; Wu Y; Wang G; Gui Z; Zhang M
    Biochem Biophys Rep; 2024 Mar; 37():101600. PubMed ID: 38371527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of necroptosis-related genes predicts the prognosis of pancreatic adenocarcinoma.
    Luo Z; Wang L; Shang Z; Guo Q; Liu Q; Zhang M; Li T; Wang Y; Zhang Y; Zhang Y; Zhang X
    Transl Oncol; 2022 Aug; 22():101462. PubMed ID: 35635957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
    Li A; Hou S; Chen J; Jiang Y
    Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiomics integrative analysis for gene signatures and prognostic values of m
    Gao W; Cheng L; He S; Li W; Zhou C; Zhou B; Liu J; Xu J; Yu X; Zhu H
    Aging (Albany NY); 2020 Oct; 12(20):20587-20610. PubMed ID: 33082301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma.
    Ma Y; Tang R; Huang P; Li D; Liao M; Gao S
    Front Pharmacol; 2024; 15():1332042. PubMed ID: 38572434
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive Analysis of 5-Methylcytosine (m
    Wang R; Guo Y; Ma P; Song Y; Min J; Zhao T; Hua L; Zhang C; Yang C; Shi J; Zhu L; Gan D; Li S; Li J; Su H
    Front Oncol; 2022; 12():851766. PubMed ID: 35433474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 19. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma.
    Xu D; Qin R; Li M; Shen J; Mao Y; Tang K; Zhang A; Wang D; Shi Y
    Medicine (Baltimore); 2022 Nov; 101(46):e29683. PubMed ID: 36401386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.